ARTICLE | Company News
Ablynx, Antitope deal
August 30, 2010 7:00 AM UTC
Antitope will use its EpiScreen immunogenicity testing technology to profile Nanobodies from Ablynx. A Nanobody is a functional antigen-binding domain derived from an antibody-heavy chain. Further det...